Cargando…
Combining preclinical tools and models to unravel tumor complexity: Jump into the next dimension
Tumors are complex and heterogeneous diseases characterized by an intricate milieu and dynamically in connection with surrounding and distant tissues. In the last decades, great efforts have been made to develop novel preclinical models able to recapitulate the original features of tumors. However,...
Autores principales: | Miserocchi, Giacomo, Bocchini, Martine, Cortesi, Michela, Arienti, Chiara, De Vita, Alessandro, Liverani, Chiara, Mercatali, Laura, Bravaccini, Sara, Ulivi, Paola, Zanoni, Michele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080004/ https://www.ncbi.nlm.nih.gov/pubmed/37033986 http://dx.doi.org/10.3389/fimmu.2023.1171141 |
Ejemplares similares
-
Management and potentialities of primary cancer cultures in preclinical and translational studies
por: Miserocchi, Giacomo, et al.
Publicado: (2017) -
Precision Medicine in Head and Neck Cancers: Genomic and Preclinical Approaches
por: Miserocchi, Giacomo, et al.
Publicado: (2022) -
The Effect of Everolimus in an In Vitro Model of Triple Negative Breast Cancer and Osteoclasts
por: Mercatali, Laura, et al.
Publicado: (2016) -
mTOR inhibitor and bone-targeted drugs break the vicious cycle between clear-cell renal carcinoma and osteoclasts in an in vitro co-culture model
por: Spadazzi, Chiara, et al.
Publicado: (2019) -
Emerging Roles of Aldehyde Dehydrogenase Isoforms in Anti-cancer Therapy Resistance
por: Zanoni, Michele, et al.
Publicado: (2022)